Delia Rota Scalabrini

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

Simonetta Viviani, Pier Luigi Zinzani, Alessandro Rambaldi et al. · New England Journal of Medicine · 2011 · 422 citations · Full text

Medicine, Oncology, Chemotherapy +11

Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

Marco Ladetto, Federica De Marco, Fabio Benedetti et al. · Blood · 2008 · 253 citations · Full text

Medicine, Immunology, Oncology +11

VEPEMB in elderly Hodgkin’s lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study

Alessandro Levis, Alessandro Anselmo, Alberto Ambrosetti et al. · Annals of Oncology · 2003 · 84 citations · Full text

Medicine, Hematology, Oncology +7

Percutaneous Vertebroplasty in Multiple Myeloma: Prospective Long-Term Follow-Up in 106 Consecutive Patients

Giovanni Carlo Anselmetti, Antonio Manca, Filippo Montemurro et al. · CardioVascular and Interventional Radiology · 2011 · 71 citations · Full text

Medicine, Oncology, Orthopedic Surgery +15

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM)

Francesca Gay, Chiara Cerrato, Delia Rota Scalabrini et al. · Blood · 2018 · 54 citations · Full text

Medicine, Oncology, Pharmacotherapy +17